128 related articles for article (PubMed ID: 11814648)
1. Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1.
Morton RA; Kuenzi FM; Fitzjohn SM; Rosahl TW; Smith D; Zheng H; Shearman M; Collingridge GL; Seabrook GR
Neurosci Lett; 2002 Feb; 319(1):37-40. PubMed ID: 11814648
[TBL] [Abstract][Full Text] [Related]
2. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1.
Parent A; Linden DJ; Sisodia SS; Borchelt DR
Neurobiol Dis; 1999 Feb; 6(1):56-62. PubMed ID: 10078973
[TBL] [Abstract][Full Text] [Related]
3. Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease.
Gelman S; Palma J; Tombaugh G; Ghavami A
J Alzheimers Dis; 2018; 61(1):195-208. PubMed ID: 29154272
[TBL] [Abstract][Full Text] [Related]
4. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
5. Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine.
Zaman SH; Parent A; Laskey A; Lee MK; Borchelt DR; Sisodia SS; Malinow R
Neurobiol Dis; 2000 Feb; 7(1):54-63. PubMed ID: 10671322
[TBL] [Abstract][Full Text] [Related]
6. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice.
Yu H; Saura CA; Choi SY; Sun LD; Yang X; Handler M; Kawarabayashi T; Younkin L; Fedeles B; Wilson MA; Younkin S; Kandel ER; Kirkwood A; Shen J
Neuron; 2001 Sep; 31(5):713-26. PubMed ID: 11567612
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the involvement of calbindin D28k in the presenilin 1 model of Alzheimer's disease.
Odero GL; Oikawa K; Glazner KA; Schapansky J; Grossman D; Thiessen JD; Motnenko A; Ge N; Martin M; Glazner GW; Albensi BC
Neuroscience; 2010 Aug; 169(1):532-43. PubMed ID: 20399254
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of the Hippocampal POMC/MC4R Circuit Alleviates Synaptic Plasticity Impairment in an Alzheimer's Disease Model.
Shen Y; Tian M; Zheng Y; Gong F; Fu AKY; Ip NY
Cell Rep; 2016 Nov; 17(7):1819-1831. PubMed ID: 27829153
[TBL] [Abstract][Full Text] [Related]
9. Synaptic fatigue is more pronounced in the APP/PS1 transgenic mouse model of Alzheimer's disease.
Zhang H; Gong B; Liu S; Fa' M; Ninan I; Staniszewski A; Arancio O
Curr Alzheimer Res; 2005 Apr; 2(2):137-40. PubMed ID: 15974910
[TBL] [Abstract][Full Text] [Related]
10. Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices.
Wang Y; Greig NH; Yu QS; Mattson MP
Neurobiol Aging; 2009 Jul; 30(7):1061-8. PubMed ID: 18068871
[TBL] [Abstract][Full Text] [Related]
11. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
12. Presenilin-1 deficiency impairs glutamate-evoked intracellular calcium responses in neurons.
Yang Y; Cook DG
Neuroscience; 2004; 124(3):501-5. PubMed ID: 14980721
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent impairment of spine morphology and synaptic plasticity in hippocampal CA1 neurons of a presenilin 1 transgenic mouse model of Alzheimer's disease.
Auffret A; Gautheron V; Repici M; Kraftsik R; Mount HT; Mariani J; Rovira C
J Neurosci; 2009 Aug; 29(32):10144-52. PubMed ID: 19675248
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.
Sadowski M; Pankiewicz J; Scholtzova H; Ji Y; Quartermain D; Jensen CH; Duff K; Nixon RA; Gruen RJ; Wisniewski T
J Neuropathol Exp Neurol; 2004 May; 63(5):418-28. PubMed ID: 15198121
[TBL] [Abstract][Full Text] [Related]
16. Age-related synaptic dysfunction in Tg2576 mice starts as a failure in early long-term potentiation which develops into a full abolishment of late long-term potentiation.
Fernández-Fernández D; Dorner-Ciossek C; Kroker KS; Rosenbrock H
J Neurosci Res; 2016 Mar; 94(3):266-81. PubMed ID: 26629777
[TBL] [Abstract][Full Text] [Related]
17. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
18. APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
Breyhan H; Wirths O; Duan K; Marcello A; Rettig J; Bayer TA
Acta Neuropathol; 2009 Jun; 117(6):677-85. PubMed ID: 19387667
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory.
Gong B; Cao Z; Zheng P; Vitolo OV; Liu S; Staniszewski A; Moolman D; Zhang H; Shelanski M; Arancio O
Cell; 2006 Aug; 126(4):775-88. PubMed ID: 16923396
[TBL] [Abstract][Full Text] [Related]
20. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
